Asgard Therapeutics is a Biotechnology Company.
Asgard Therapeutics has raised $32.6M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Asgard Therapeutics's investors include Novo Holdings, Boehringer Ingelheim Venture Fund, Johnson & Johnson Innovation – JJDC, Industrifonden, LU Innovation.
Asgard Therapeutics is headquartered in Lund, Sweden.
Asgard Therapeutics is a Biotechnology Company.
Asgard Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Asgard Therapeutics — Funding & Investors." VCBacked, March 14, 2024, https://www.vcbacked.co/company/asgard-therapeutics. Accessed July 27, 2026.
VCBacked. (2024). Asgard Therapeutics — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/asgard-therapeutics
{{cite web |title=Asgard Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/asgard-therapeutics |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated